Glaucoma News

CHICAGO — In this Healio Video Perspective from the AAO meeting, Steven R. Sarkisian, MD, discusses data from a phase 2 trial investigating the iDose sustained-release travoprost implant from Glaukos for the treatment of glaucoma.

CHICAGO — Evidence suggests that selective laser trabeculoplasty could be the standard of care for patients with glaucoma, according to a speaker here.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Shawn O’Neil of ViaLase discusses the company’s noninvasive OCT-driven femtosecond laser for glaucoma treatment.

MILAN — During iNovation Day at the ESCRS meeting, Philippe Sourdille, MD, presented the Cilio-scleral Inter-positioning Device from Ciliatech for the surgical treatment of glaucoma.

Santen and UBE announced the FDA approval of Omlonti for the reduction of elevated IOP in patients with primary open-angle glaucoma or ocular hypertension.

MILAN — Earlier intervention is the future of glaucoma, a switch to a proactive approach leading to improved compliance, reduced costs and better quality of life, according to Ike Ahmed, MD.

MONTEREY, Calif. — Fewer adverse events overall were reported in eyes receiving Allergan’s Xen gel stent to treat glaucoma vs. eyes undergoing trabeculectomy at 12 months in the Gold Standard Pathway Study, according to a poster.

MONTEREY, Calif. — MicroPulse transscleral laser therapy delivered with a functionally and ergonomically revised probe resulted in a greater IOP-lowering effect while maintaining the safety profile of the original, according to a poster.

Iantrek announced it closed $23 million in Series B financing that will go toward initiating clinical trials of its MIGS devices, according to a press release.

One of the most common questions I get asked by my patients with glaucoma is, “Doc, what else can I do to help my disease and prevent blindness?”